TY - JOUR
T1 - Reduced fetal movements at term in singleton low risk pregnancies—Is there an association with placental histopathological findings?
AU - Levy, Michal
AU - Kovo, Michal
AU - Izaik, Yakira
AU - Luwisch Cohen, Isca
AU - Schreiber, Letizia
AU - Ganer Herman, Hadas
AU - Barda, Giulia
AU - Bar, Jacob
AU - Weiner, Eran
N1 - Publisher Copyright:
© 2020 Nordic Federation of Societies of Obstetrics and Gynecology
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Introduction: Maternal perception of fetal movements has long been considered an indicator of fetal well-being. A sudden decrease in the number of fetal movements is suggestive of fetal compromise. We aimed to determine whether the maternal perception of reduced fetal movements (RFM) is associated with placental pathological lesions in a low-risk term population. Material and methods: Our study was a case-control study that was performed in a single university center. Placental histopathology, maternal demographics, labor characteristics, and neonatal outcomes of term, singleton pregnancies with maternal perception of RFM during the 2 weeks prior to delivery were collected. To isolate the effect of RFM on placental pathology, we excluded cases complicated by preterm birth, hypertensive disorders, diabetes mellitus, small-for-gestational-age and congenital/genetic anomalies. We compared pregnancy outcomes and placental pathology between the RFM group and a control group matched for gestational age and mode of delivery. Placental lesions were classified according to the “Amsterdam” criteria. Composite adverse neonatal outcome was defined as one or more of the following: sepsis, transfusion, hypoglycemia, phototherapy, respiratory morbidity, cerebral morbidity, necrotizing enterocolitis and fetal/neonatal death. Multivariable regression analysis was performed to identify independent associations with adverse neonatal outcome. Results: We included patients who gave birth from January 2008 until May 2019. The study group included 203 term pregnancies with RFM during the 2 weeks prior to delivery, which was matched with 203 controls. The RFM group was characterized by a higher rate of placental weight <10th percentile (22.6% vs. 3.9%, P <.001), a higher rate of maternal vascular malperfusion lesions (30.5% vs. 18.7%, P =.007) and lesions of maternal inflammatory response (43.3% vs. 29.5%, P =.005). At delivery, the RFM group had higher rates of cesarean delivery due to non-reassuring fetal heart rate monitoring (P =.01), 5-minute Apgar score ≤7 (P =.03), neonatal intensive care unit admissions (P <.001) and composite adverse neonatal outcomes (P =.007). Using multivariable analysis, RFM (adjusted odds ratio [aOR] 1.7, 95% confidence interval [CI] 1.1-4.8), and placental maternal vascular malperfusion lesions (aOR 1.2, 95% CI 1.0-2.9) were independently associated with adverse neonatal outcome. Conclusions: After excluding important placental-related morbidities, RFM was associated with a higher rate of placental weight <10th percentile and placental maternal vascular malperfusion lesions vs. controls. This study suggests a placental involvement in the association between RFM at term and adverse pregnancy outcomes.
AB - Introduction: Maternal perception of fetal movements has long been considered an indicator of fetal well-being. A sudden decrease in the number of fetal movements is suggestive of fetal compromise. We aimed to determine whether the maternal perception of reduced fetal movements (RFM) is associated with placental pathological lesions in a low-risk term population. Material and methods: Our study was a case-control study that was performed in a single university center. Placental histopathology, maternal demographics, labor characteristics, and neonatal outcomes of term, singleton pregnancies with maternal perception of RFM during the 2 weeks prior to delivery were collected. To isolate the effect of RFM on placental pathology, we excluded cases complicated by preterm birth, hypertensive disorders, diabetes mellitus, small-for-gestational-age and congenital/genetic anomalies. We compared pregnancy outcomes and placental pathology between the RFM group and a control group matched for gestational age and mode of delivery. Placental lesions were classified according to the “Amsterdam” criteria. Composite adverse neonatal outcome was defined as one or more of the following: sepsis, transfusion, hypoglycemia, phototherapy, respiratory morbidity, cerebral morbidity, necrotizing enterocolitis and fetal/neonatal death. Multivariable regression analysis was performed to identify independent associations with adverse neonatal outcome. Results: We included patients who gave birth from January 2008 until May 2019. The study group included 203 term pregnancies with RFM during the 2 weeks prior to delivery, which was matched with 203 controls. The RFM group was characterized by a higher rate of placental weight <10th percentile (22.6% vs. 3.9%, P <.001), a higher rate of maternal vascular malperfusion lesions (30.5% vs. 18.7%, P =.007) and lesions of maternal inflammatory response (43.3% vs. 29.5%, P =.005). At delivery, the RFM group had higher rates of cesarean delivery due to non-reassuring fetal heart rate monitoring (P =.01), 5-minute Apgar score ≤7 (P =.03), neonatal intensive care unit admissions (P <.001) and composite adverse neonatal outcomes (P =.007). Using multivariable analysis, RFM (adjusted odds ratio [aOR] 1.7, 95% confidence interval [CI] 1.1-4.8), and placental maternal vascular malperfusion lesions (aOR 1.2, 95% CI 1.0-2.9) were independently associated with adverse neonatal outcome. Conclusions: After excluding important placental-related morbidities, RFM was associated with a higher rate of placental weight <10th percentile and placental maternal vascular malperfusion lesions vs. controls. This study suggests a placental involvement in the association between RFM at term and adverse pregnancy outcomes.
KW - malperfusion lesions
KW - neonatal outcome
KW - placental pathology
KW - reduced fetal movements
KW - term pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85079459835&partnerID=8YFLogxK
U2 - 10.1111/aogs.13810
DO - 10.1111/aogs.13810
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 31960411
AN - SCOPUS:85079459835
SN - 0001-6349
VL - 99
SP - 884
EP - 890
JO - Acta Obstetricia et Gynecologica Scandinavica
JF - Acta Obstetricia et Gynecologica Scandinavica
IS - 7
ER -